Risk of congestive heart failure in an elderly population treated with peripheral alpha-1 antagonists

Journal of the American Geriatrics Society

Volumn 52, Issue 10, 2004, Pages 1648-1654

  Bryson, Chris L ^a,h   Smith, Nicholas L ^b   Kuller, Lewis H ^b   Chaves, Paulo H M ^d   Manolio, Teri A ^e   Lewis, William ^f   Boyko, Edward J ^a   Furberg, Curt D ^g   Psaty, Bruce M ^c  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g WAKE FOREST UNIVERSITY   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alpha 1 antagonist; Heart failure; Hypertension treatment; Thiazide

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; THIAZIDE DIURETIC AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BENZOTHIADIAZINE DERIVATIVE; DIURETIC AGENT;

AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; POPULATION; PROSPECTIVE STUDY; PROSTATISM; SYSTOLIC BLOOD PRESSURE; UNITED STATES; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; RISK FACTOR;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; ANTIHYPERTENSIVE AGENTS; BENZOTHIADIAZINES; BLOOD PRESSURE; COHORT STUDIES; DIURETICS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; RISK FACTORS; SODIUM CHLORIDE SYMPORTER INHIBITORS; UNITED STATES;

EID: 6944231103     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2004.52456.x     Document Type: Article

References (21)

1. Psaty BM, Smith NL, Siscovick DS et al. Health outcomes associated with antihypertensive therapies used as first-line agents: A systematic review and meta-analysis. JAMA 1997;277:739-745.
2. Kostis JB, Davis BR, Cutler J et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension: SHEP Cooperative Research Group. JAMA 1997;278:212-216.
3. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000;283:1967-1975.
4. Psaty BM, Manolio TA, Smith NL et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults: The Cardiovascular Health Study. Arch Intern Med 2002;162:2325-2332.
5. Fried LP, Borhani NO, Enright P et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1991;1:263-276.
6. Psaty BM, Kuller LH, Bild D et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 1995;5:270-277.
7. Gardin JM, Wong ND, Bommer W et al. Echocardiographic design of a multicenter investigation of free-living elderly subjects: The Cardiovascular Health Study. J Am Soc Echocardiogr 1992;5:63-72.
8. Psaty BM, Lee M, Savage PJ et al. Assessing the use of medications in the elderly: Methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol 1992;45:683-692.
9. Ives DG, Fitzpatrick AL., Bild DE et al. Surveillance and ascertainment of cardiovascular events: The Cardiovascular Health Study. Ann Epidemiol 1995;5:278-285.
10. Vasan RS, Larson MG, Benjamin EJ et al. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33: 1948-1955.
11. Davis BR, Cutler JA, Furberg CD et al. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: Further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial. Ann Intern Med 2002;137:313-320.
12. Tamasawa N, Matsui J, Ogawa Y et al. Effect of doxazosin on the size of LDL particle in the type 2 diabetic patients with hypertension. J Diabetes Complications 2000;14:135-139.
13. Andersen P, Seljeflot I, Herzog A et al. Effects of doxazosin and atenolol on atherothrombogenic risk profile in hypertensive middle-aged men. J Cardiovasc Pharmacol 1998;31:677-683.
14. Grimm RH, Flack JM, Grandits GA et al. Long-term effects on plasma lipids of diet and drugs to treat hypertension: Treatment of Mild Hypertension Study (TOMHS) Research Group. JAMA 1996;275:1549-1556.
15. Carruthers G, Dessain P, Fodor G et al. Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension: The Alpha Beta Canada Trial Group. Am J Cardiol 1993;71:575-581.
16. Bryson CL, Psaty BM. A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy. Curr Control Trials Cardiovasc Med 2002;3:1-7.
17. Hooper PL. Reduced heat shock proteins: A mechanism to explain higher cardiovascular events associated with doxazosin. J Hum Hypertens 2001;15:285.
18. Aronow WS, Ahn C. Incidence of new coronary events in older persons with prior myocardial infarction and systemic hypertension treated with beta blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium antagonists, and alpha blockers. Am J Cardiol 2002;89:1207-1209.
19. Materson BJ. Single-drug therapy for hypertension in men: A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-921.
20. Gandhi SK, Powers JC, Nomeir AM et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001;344:17-22.
21. Furberg CD, Psaty BM, Pahor M et al. Clinical Implications of recent findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and other studies of hypertension. Ann Intern Med 2001;135:1074-1078.